BioSenic appoints Yves Sagot as Independent Director

BioSenic appoints Yves Sagot as Independent Director Mont-Saint-Guibert, Belgium, January 27, 2023 – BioSenic (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune / inflammatory diseases and cell repair, today announces the appointment of Yves Sagot...

Related Keywords

Mont Saint Guibert ,Waals Gewest ,Belgium ,Paris ,France General ,France ,Switzerland ,Swiss ,Merck Serono ,Yves Sagot ,Terry Sadler ,Yves Sadler ,Management Of Technology ,Cancer Center ,Euronext Brussels ,Relief Therapeutics ,Chief Scientific Officer ,Merck Serono Reward ,Recognition Award ,Independent Director ,Chief Medical Officer ,Advanced Studies ,Pharma Ventures ,Fundamental Toxicology ,Paul Sabatier ,